YOLFTbeta
Aqua Bio Technology ASA

Aqua Bio Technology ASA

ABTEC · OL · Healthcare / Biotechnology

4.29NOK-0.42 (-8.92%)

Price History

Full chart

Market Stats

Previous Close4.71
Open4.29
Day Range4.29 – 4.29
52-Week Range4.00 – 35.00
Volume190
Market Cap73.41M
P/E (TTM)0.00
Forward P/E0.00
EPS-62.51
Dividend Yield0.00%
Beta0.23
50-Day Avg4.90
200-Day Avg7.70

About

Aqua Bio Technology ASA, together with its subsidiary, develops and sells ingredients for skin care products in Norway. The company offers Aquabeautine XL, a proprietary ingredient for skincare products; and Spirulysat, an antioxidant and vitamin-boosted spirulina for cosmetic use. It also provides freight logistics solutions for trading companies. The company distributes its products through internet, stores, and skincare clinics. Aqua Bio Technology ASA was founded in 2000 and is headquartered in Oslo, Norway.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Kristian Flaten
  • Employees2
  • HeadquartersKarenslyst Allé 10, Oslo, Norway, 0278, Norway
  • Websitehttps://aquabiotechnology.com

Leadership

  • Mr. Kristian FlatenCEO & CFO · b. 1972
  • Mr. Espen Østhagen KvaleChief Operating Officer · b. 1976
  • Mr. Hans Kristian LerenChief Technology Officer

Financials

Income Statement

Currency: NOK2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue01.21M878.14K891.47K444.38K1.56M7.02M18.41M106.56M1.34M
Growth (%)---27.65%+1.52%-50.15%+250.98%+349.88%+162.31%+478.93%-98.74%
Cost of Revenue01.35M2.15M1.42M981.49K951.78K4.69M8.34M104.54M1.11M
Gross Profit0-139.07K-1.27M-529.59K-537.11K607.92K2.33M10.07M2.01M225.50K
Gross Margin--11.46%-144.35%-59.41%-120.87%38.98%33.17%54.71%1.89%16.84%
Operating Expense-2.86M14.74M37.20M12.59M15.57M18.47M18.70M25.85M327.73M12.18M
Operating Income2.86M-14.88M-38.47M-13.12M-16.10M-17.86M-16.37M-15.78M-325.71M-11.95M
Operating Margin--1225.70%-4381.01%-1472.24%-3624.09%-1144.91%-233.27%-85.76%-305.67%-892.64%
EBITDA-------14.85M-12.67M64.50M-5.73M
EBITDA Margin-------211.57%-68.84%60.53%-427.65%
Net Income1.46M-16.06M-38.47M-13.22M-14.70M-19.11M-18.74M-21.02M-337.35M97.71M
Net Income Margin--1323.00%-4380.40%-1482.44%-3308.86%-1225.41%-267.01%-114.22%-316.59%7297.73%
Interest Expense-----1.46M2.24M4.49M19.01M12.22M
Interest Expense % of Total Revenue-----93.30%31.89%24.39%17.84%912.63%

Balance Sheet

Currency: NOK2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets71.42M49.09M9.94M10.39M16.24M34.43M67.20M237.74M249.70M130.02M
Total Liabilities9.65M10.56M10.13M3.06M7.92M15.72M65.34M151.97M331.44M130.51M
Total Equity61.77M38.53M-197.16K7.32M8.32M18.71M1.86M85.78M-81.74M-489.07K
Cash-----12.95M1.48M4.42M16.79M2.43M
Net Debt------14.42M27.76M128.12M106.34M

Cash Flow

Currency: NOK2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-25.79M-16.36M-17.23M-17.19M-13.34M-20.97M-15.45M-19.27M-46.85M-8.15M
Investing Cash Flow--408.26K-935.50K-358.44K-17.84K-3.27M-5.41M-4.09M-1.40M12.97M-
Financing Cash Flow--20.49M-7.06M-983.35K20.71M15.16M34.30M8.04M23.65M46.24M-
Capital Expenditure0408.26K935.50K358.44K17.84K135.69K3.87M01.41M1.08M0
Free Cash Flow-------24.84M-15.45M-20.68M-47.93M-8.15M
Dividends Paid-16.92M6.22M--------
FCF to OCF------118.44%100.00%107.30%102.30%100.00%

Earnings

Report DateMar 31, 2008Jun 30, 2008Sep 30, 2008Dec 31, 2008Mar 31, 2009Jun 30, 2009Sep 30, 2009Mar 3, 2010Jun 2, 2010Sep 1, 2010Nov 30, 2010Feb 18, 2011Jun 1, 2011Aug 28, 2011Nov 30, 2011Feb 17, 2012May 23, 2012Aug 28, 2012Nov 27, 2012Feb 12, 2013May 22, 2013Aug 21, 2013Nov 27, 2013Feb 12, 2014Apr 9, 2014Aug 20, 2014Nov 26, 2014Feb 10, 2015May 13, 2015Aug 19, 2015Nov 18, 2015Feb 10, 2016May 11, 2016Aug 17, 2016Nov 17, 2016Feb 15, 2017May 16, 2017Aug 16, 2017Feb 21, 2018May 23, 2018Aug 22, 2018Nov 28, 2018Apr 24, 2019Aug 28, 2019Nov 27, 2019Apr 15, 2020Aug 26, 2020Nov 18, 2020Feb 17, 2021May 18, 2021Aug 25, 2021Nov 17, 2021Apr 29, 2022Aug 24, 2022Nov 16, 2022Apr 27, 2023Aug 24, 2023Nov 15, 2023Apr 26, 2024Aug 23, 2024Nov 6, 2024Feb 12, 2025Sep 30, 2025
EPS Estimate-----------20.00-20.00--15.50-22.50-31.5076.00-28.50--4.5010.009.00-1.50-0.50--5.0016.5024.0028.5030.0040.5012.5049.0054.500.000.00-0.500.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00-
EPS Actual-184.84-187.64-180.23-509.49-92.43-36.95-27.71-27.71-27.71-37.53-2000.00-70.00-28.24-33.59-18.50-44.5072.50-40.00-4.32-23.0018.0010.504.00-13.92-13.50-0.240.2710.5029.5023.5019.5034.0020.50-5.0032.1029.000.00-0.41-1.910.00-1.300.00-1.34-0.750.00-0.31-0.420.00-0.480.00-0.500.00-0.52-0.610.00-0.300.000.000.000.000.000.00-2.40
Surprise-----------9900.00%-250.00%--116.71%17.78%-41.27%-4.61%-40.35%--411.11%80.00%16.67%366.67%--2800.00%--110.00%78.79%-2.08%-31.58%13.33%-49.38%-140.00%-34.49%-46.79%---282.00%------------------------
Timing----------Pre-marketPre-market-After-hoursPre-marketAfter-hoursAfter-hours--After-hours-Pre-marketAfter-hours--Pre-marketPre-marketAfter-hours--Pre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-market-------------------------

Key Statistics & Ratios

Market Cap73.41M
Enterprise Value144.85M
Trailing P/E0.00
Forward P/E0.00
Price / Sales12.96
Price / Book1.83
EPS-62.51
Book Value2.77
Revenue (TTM)5.67M
Gross Profit (TTM)4.55M
EBITDA-8.62M
Profit Margin0.00%
Operating Margin-898.05%
Return on Equity-115.14%
Return on Assets-1.84%
Shares Outstanding15.49M
Shares Float4.34M
Beta0.23
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20171×
49.69Jun 8, 2017
20162×
49.69Nov 18, 201674.53Jun 9, 2016
20151×
49.69Jun 4, 2015

Stock Splits

  • Feb 27, 20261:50
  • Jun 27, 20111:20